Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Rivaroxaban-Placebo'

Rivaroxaban-Placebo published presentations and documents on DocSlides.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
by yoshiko-marsland
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
Rivaroxaban compared with enoxaparin for the prevention of
Rivaroxaban compared with enoxaparin for the prevention of
by luanne-stotts
Alexander T Cohen . On behalf of the MAGELLAN Ste...
Recent ACS: STEMI, NSTEMI, UA
Recent ACS: STEMI, NSTEMI, UA
by danika-pritchard
Stabilized 1-7 Days Post-Index Event. Exclusions:...
Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:
Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:
by giovanna-bartolotta
Rivaroxaban Plus Aspirin in Patients With and Wit...
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
by LittleMissPerfect
rivaroxaban. group vs. 1.02% of the vitamin K ant...
Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding
Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding
by kyle585
Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....
Review on NOACs Studies Dr.
Review on NOACs Studies Dr.
by BlessedBeyondMeasure
Kourosh. . Sadeghi. Tehran University of medical ...
MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,
MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,
by HoneyBun
VTE death. ) for . rivaroxaban. vs. . enoxaparin....
Thromboembolic protocols
Thromboembolic protocols
by cecilia
& safe anticoagulant prescribing. July 2020. D...
Rivaroxaban in stable peripheral or carotid artery disease
Rivaroxaban in stable peripheral or carotid artery disease
by basidell
Sonia Anand, on . behalf of the COMPASS Steering C...
A ssessment of D ual antiplatelet therapy versus
A ssessment of D ual antiplatelet therapy versus
by coursion
R. ivaroxaban . I. n atrial . F. ibrillation patie...
Ima A. Kusuma , MD, FIHA
Ima A. Kusuma , MD, FIHA
by hirook
“JIH. ” Hospital, Yogyakarta, Indonesia. The U...
A ssessment of D ual antiplatelet therapy versus
A ssessment of D ual antiplatelet therapy versus
by stefany-barnette
A ssessment of D ual antiplatelet therapy versus...
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
by yoshiko-marsland
Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...
CAD/PAD in Primary Care CV Risk in Stable Outpatients
CAD/PAD in Primary Care CV Risk in Stable Outpatients
by stefany-barnette
Stratified by Baseline CV Risk Category. Aspirin ...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Stroke, Bleeding, and
Stroke, Bleeding, and
by lois-ondreau
Mortality Risks . in . Elderly Medicare Beneficia...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by giovanna-bartolotta
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
New Oral Anticoagulant
New Oral Anticoagulant
by mitsue-stanley
R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...
R eal-world
R eal-world
by liane-varnes
EVI. dence. on . S. troke prevention . I. n pati...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by ellena-manuel
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Novel Oral Anticoagulants
Novel Oral Anticoagulants
by natalia-silvester
(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...
Placebo (n = 38) Metoprolol
Placebo (n = 38) Metoprolol
by unita
(. n . = 37). Metoprolol for AR. Primary endpoint,...
Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i
Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i
by delcy
syncope. Given the trend towards benefit though, i...
Placebo (n = 2,333) Empaglifozin
Placebo (n = 2,333) Empaglifozin
by SugarPlumFairy
(. n . = 4,687). EMPA-REG OUTCOME. Primary . outco...
Alpha Omega MACE: 14.0% with EPA-DHA vs. 13.8% with placebo (p = 0.93)
Alpha Omega MACE: 14.0% with EPA-DHA vs. 13.8% with placebo (p = 0.93)
by delcy
MACE: 13.2% with ALA vs. 14.5% with placebo (p = 0...
Neratinib / Placebo treatment
Neratinib / Placebo treatment
by heartersh
0. 3. 6. 9. 12. 15. 18. 21. 24. Disease-free survi...
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
by mitsue-stanley
ASCEND Randomized placebo-controlled trial of as...
Causal diagrams, the placebo effect, and the expectation effect
Causal diagrams, the placebo effect, and the expectation effect
by ellena-manuel
Eyal Shahar, MD, MPH. Professor. (. c. redit to D...
Anxiolytic Placebo Response in Outbred Mice
Anxiolytic Placebo Response in Outbred Mice
by natalia-silvester
Kelsey I. . Landaverde. , Stacey L. . Kirkpatrick...
What Accounts for Placebo Group
What Accounts for Placebo Group
by alida-meadow
Improvements and Can They Be Reduced?. John T. Fa...
Does Meditation Really Work or It’s Placebo effect
Does Meditation Really Work or It’s Placebo effect
by ellena-manuel
Simge ALTINKÖK. Outline. Definition of meditati...
The Placebo Effect
The Placebo Effect
by danika-pritchard
. ...
The Placebo Effect
The Placebo Effect
by alexa-scheidler
Homeopathy. In the late 1700’s a German doctor ...
The Placebo Drift Debate in Antidepressant Clinical Trials
The Placebo Drift Debate in Antidepressant Clinical Trials
by celsa-spraggs
Zach Daniel White. Biology 101h- . Desaix. Why do...
Figure 1 Figure 1. Estimated and observed viral load following treatment with placebo (A) or Paxlov
Figure 1 Figure 1. Estimated and observed viral load following treatment with placebo (A) or Paxlov
by gian
Bai Y, Du Z, Wang L, Lau E, Fung I, Holme P, et al...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
by zen
knowledge. ). Incorporate evidence-based research ...